Canada Pension Plan Investment Board’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
VPM
VCM
QCM
Canada Pension Plan Investment Board's NVCR Position: Q1 2026 in Review
Canada Pension Plan Investment Board reduced its NovoCure (NVCR) stake by 79% in Q1 2026, selling an estimated $862K and leaving 17,900 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.
Canada Pension Plan Investment Board first reported a position in NVCR in Q3 2018 and has held it in 18 quarters since. The position peaked at $8.05M in Q2 2020. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.
- Canada Pension Plan Investment Board held 17,900 shares of NovoCure worth $195K as of Q1 2026.
- Canada Pension Plan Investment Board sold 69,000 NovoCure shares in Q1 2026, an estimated $862K.
- NovoCure made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1574 holding.
- Canada Pension Plan Investment Board first reported a position in NovoCure in Q3 2018 and has held it in 18 quarters since.
- Canada Pension Plan Investment Board's NovoCure position peaked at $8.05M in Q2 2020.
- 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.